Experimental evolution of resistance to an antimicrobial peptide

Proceedings of the Royal Society B: Biological Sciences

Volumn 273, Issue 1583, 2006, Pages 251-256

  Perron, Gabriel G ^a   Zasloff, Michael ^b   Bell, Graham ^a  

^a MCGILL UNIVERSITY   (Canada)

^b GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Antibiotic resistance; Antimicrobial peptides; Escherichia coli; Experimental evolution; Pseudomonas fluorescens; Selection experiment

Indexed keywords

PEXIGANAN ACETATE; POLYPEPTIDE ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; ANTIMICROBIAL CATIONIC PEPTIDE; PEXIGANAN;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; CATION; COLIFORM BACTERIUM; EXPERIMENTAL STUDY; GENETICS; MODEL; PEPTIDE; SELECTION;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL CELL; BACTERIAL GROWTH; CONTROLLED STUDY; DRUG ISOLATION; ESCHERICHIA COLI; GROWTH INHIBITION; LABORATORY TEST; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS FLUORESCENS; ANIMAL; DIRECTED MOLECULAR EVOLUTION; DRUG EFFECT; GENETICS;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; PSEUDOMONAS FLUORESCENS;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; DIRECTED MOLECULAR EVOLUTION; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; PSEUDOMONAS FLUORESCENS;

EID: 33645834508     PISSN: 09628452     EISSN: 14712970     Source Type: Journal    
DOI: 10.1098/rspb.2005.3301     Document Type: Article

References (37)

1. Andreu, D. J. & Rivas, L. 1998 Animal antimicrobial peptides: an overview. Biopolymer 47, 415-433. (doi:10.1002/(SICI)1097- 0282(1998)47:6〈415::AID-BIP2〉3.0.CO;2-D)
2. Barbosa, T. M. & Levy, S. B. 2000 The impact of antibiotic use on resistance development and persistence. Drug Resist. Update. 3, 303-311. (doi:10.1054/drup.2000.0167)
3. Bell, G. & Gouyon, P. H. 2003 Arming the enemy: the evolution of resistance to self-proteins. Microbiology 149, 1367-1375. (doi:10.1099/mic.0.C0122-0)
4. Brogden, K. A. 2005 Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat. Rev. Microbiol. 3, 238-250. (doi:10.1038/nrmicro1098)
5. Chopra, I., O'Neill, A. J. & Miller, K. 2003 The role of mutators in the emergence of antibiotic-resistant bacteria. Drug Resist. Update. 6, 137-145. (doi:10.1016/S1368-7646(03)00041-4)
6. Devine, D. A. & Hancock, R. E. W. 2002 Cationic peptides: distribution and mechanisms of resistance. Curr. Pharm. Design 8, 703-714. (doi:10.2174/1381612023395501)
7. Fedtke, I., Gotz, F. & Peschel, A. 2004 Bacterial evasion of innate host defenses - the Staphylococcus aureus lesson. Int. J. Med. Microbiol. 294, 189-194. (doi:10.1016/j.ijmm.2004.06.016)
8. Ge, Y., MacDonald, D. L., Holroyd, K. J., Thornsberry, C., Wexler, H. & Zasloff, M. 1999a In vitro antibacterial properties of pexiganan, an analog of magainin. Antimicrob. Agents Chemother. 43, 782-788.
9. Ge, Y., MacDonald, D., Henry, M. H., Hait, H. I., Nelson, K. A., Lipsky, B. A., Zasloff, M. & Holroyd, K. J. 1999b In vitro susceptibility to pexiganan of bacteria isolated from infected diabetic foot ulcer. Diagn. Microbiol. Infect. Dis. 35, 45-53. (doi:10.1016/S0732(99)00053-X)
10. Groisman, E. A., Parra-Lopez, C., Salcedo, M., Lipps, C. J. & Heffron, F. 1992 Resistance to host peptides is necessary for Salmonella virulence. Proc. Natl Acad. Sci. USA 89, 11 939-11 943.
11. Guo, L., Lim, K. B., Poduje, C. M., Daniel, M., Gunn, J. S., Haclett, M. & Miller, S. I. 1998 Lipid A acetylation and bacterial reistance against vertebrate antimicrobial peptides. Cell 95, 189-198. (doi:10.1016/S0092-8674(00)81750-X)
12. Hancock, R. E. M. 1997 Peptides antibiotics. Lancet 349, 418-442. (doi:10.1016/S0140-6736(97)80051-7)
13. Hancock, R. E. M. 2001 Cationic peptides: effectors in innate immunity and novel antimicrobials. Lancet Infect. Dis. 1, 156-164. (doi:10.1016/S1473-3099(01)00092-5)
14. Hancock, R. E. M. & Chapple, D. S. 1999 Peptide antibiotics. Antimicrob. Agents Chemother. 43, 1317-1323.
15. Hancock, R. E. W., Falla, T. & Brown, M. M. 1995 Cationic bactericidal peptides. Adv. Microb. Physiol. 13, 135-175.
16. Hartl, D. L. & Clark, A. G. 1997 Principles of population genetics. New York: Sinauer.
17. Huang, H. W. 2000 Action of antimicrobial peptides: two-state model. Biochemistry 39, 8347-8352. (doi:10.1021/bi000946l)
18. LeClerc, J. E., Li, B., Payne, W. L. & Cebula, T. A. 1996 High mutation frequencies among Escherichia coli and Salmonella pathogens. Science 274, 1208-1211. (doi:10.1126/science.274.5290.1208)
19. Lilley, A. K. & Bailey, M. J. 1997 The acquisition of indigenous plasmids by a genetically marked pseudomonad population colonising the phytosphere of sugar beet is related to local environmental conditions. Appl. Environ. Microbiol. 63, 1577-1583.
20. Lorian, V. 1996 Antibiotics in laboratory medicine. Baltimore, MD: Williams & Wilkins laboratory.
21. Lohner, K. & Blondelle, S. E. 2005 Molecular mechanisms of membrane perturbation by antimicrobial peptides and the use of biophysical studies in the design of novel peptide antibiotics. Comb. Chem. High Throughput Screen. 8, 241-256. (doi:10.2174/1386207053764576)
22. Martinez, J. L. & Baquero, F. 2000 Mutation frequencies and antibiotics resistance. Antimicrob. Agents Chemother. 33, 1771-1777. (doi:10.1128/AAC.44.7.1771-1777.2000)
23. Miller, K., O'Neill, A. J. & Chopra, I. 2002 Response of Escherichia coli hypermutators to selection pressure with antimicrobial agents from different classes. J. Antimocrob. Chem. 49, 925-934. (doi:10.1093/jac/dkf044)
24. NCCLS, 2003 Approved Standards (M7-A4): methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 6th edn. Villanova, PA.
25. O'Brien, T. F. 2002 Emergence, spread, and environmental effect of antimicrobial resistance: how use of an antimicrobial anywhere can increase resistance to any antimicrobial anywhere else. Clin. Infect. Dis. 34(3), S78-S84. (doi:10.1086/340244)
26. Oliver, A., Canton, R., Campo, P., Baquero, F. & Blazquez, J. 2000 High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. Science 288, 1251-1254. (doi:10.1126/science.288.5469. 1251)
27. Palumbi, S. R. 2001 Humans as the World's greatest evolutionary force. Science 293, 1786-1790. (doi:10.1126/science.293.5536.1786)
28. Peschel, A. & Collins, L. V. 2001 Staphylococcal resistance to antimicrobial peptides of mammalian and bacterial origin. Peptides 22, 1651-1659. (doi:10.1016/S0196-9781(01)00500-9)
29. Reddy, K. V. R., Yedery, R. D. & Aranha, C. 2004 Antimicrobial peptides: premises and promises. Int. J. Antimicrob. Agents 24, 536-547. (doi:10.1016/j.ijantimicag.2004.09.005)
30. Shaver, A. C. & Sniegowski, P. D. 2003 Spontaneously arising mutL mutators in evolving Esherishia coli populations are the results of changes in repeat length. J. Bacteriol. 185, 6076-6082. (doi:10.1128/JB.185.20.6076-6082.2003)
31. Sniegowski, P. D., Gerrish, P. J. & Lenski, R. E. 1997 Evolution of high mutation rates in experimental populations of E. coli. Nature 387, 703-705. (doi:10.1038/42701)
32. Tamayo, R., Choudhury, B., Septer, A., Merighi, M., Carlson, R. & Gunn, J. S. 2005 Identification of cptA, a PmrA-regulated locus required for phosphoethanolamine modification of the Salmonella enterica serovar typhimurium lipopolysaccharide core. J. Bacteriol. 187, 3391-3399. (doi:10.1128/JB.187.10.3391-3399.2005)
33. Toke, O. 2005 Antimicrobial peptides: new candidates in the fight against bacterial infections. Biopolymers (doi:10.1002/bip.20286.)
34. Vanhoye, D., Bruston, F., Nicolas, P. & Amichem, M. 2003 Antimicrobial peptides from hylid and ranin frogs originated from a 150-million-year-old ancestral precursor with a conserved signal peptide but a hypermutable antimicrobial domain. Eur. J. Biochem. 270, 2068-2081. (doi:10.1046/j.1432-1033.2003.03584.x)
35. Yeaman, M. R. & Yount, N. Y. 2003 Mechanisms of antimicrobial peptides action and resistance. Pharmacol. Rev. 55, 27-55. (doi:10.1124/pr.55.1.2)
36. Zasloff, M. 1987 Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active, and partial cDNA sequence or a precursor. Proc. Natl Acad. Sci. USA 84, 5449-5453.
37. Zasloff, M. 2002 Antimicrobial peptides of multicellular organisms. Nature 415, 389-395. (doi:10.1038/415389a)